pc ¹öÀüÀ¸·Î À̵¿ Áß [½ÃÀ庸°í¼­]¼¼°èÀÇ DNases, ¸®°¡¾ÆÁ¦, RNA ÁßÇÕÈ¿¼Ò ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® ¸®Æ÷Æ® : ÀÀ¿ëº°(DNases : ¹ÙÀÌ¿ÀÀǾàǰ °¡°ø, Ligases : ¿Ã¸®°í´ºÅ¬·¹¿ÀƼµå ÇÕ¼º), Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2022-2030³â)
¼¼°èÀÇ DNases, ¸®°¡¾ÆÁ¦, RNA ÁßÇÕÈ¿¼Ò ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® ¸®Æ÷Æ® : ÀÀ¿ëº°(DNases : ¹ÙÀÌ¿ÀÀǾàǰ °¡°ø, Ligases : ¿Ã¸®°í´ºÅ¬·¹¿ÀƼµå ÇÕ¼º), Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2022-2030³â)
DNases, Ligases, And RNA Polymerases Market Size, Share & Trends Analysis Report By Application (DNases - Biopharmaceutical Processing, Ligases - Oligonucleotide Synthesis), By Region, And Segment Forecasts, 2022 - 2030
»óǰÄÚµå : 1147462
¸®¼­Ä¡»ç : Grand View Research, Inc.
¹ßÇàÀÏ : 2022³â 10¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 142 Pages
US $ 5,950 £Ü 7,404,000
Unprintable PDF (Single User License)
US $ 6,950 £Ü 8,648,000
Printable PDF (5-User License)
US $ 8,950 £Ü 11,137,000
Printable PDF (Enterprise License)


Çѱ۸ñÂ÷

Grand View Research, Inc.ÀÇ »õ·Î¿î º¸°í¼­¿¡ µû¸£¸é ¼¼°èÀÇ DNases, ¸®°¡¾ÆÁ¦, RNA ÁßÇÕÈ¿¼Ò ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 12¾ï 8,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. 2022³âºÎÅÍ 2030³â±îÁö´Â ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR) 8.58%·Î È®´ëµÉ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¿¬±¸°³¹ßºñ Áõ°¡´Â ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎ Áß ÇϳªÀÔ´Ï´Ù. DNA °ü·Ã Çõ½Å¿¡ ´ëÇÑ ÁÖ¸ñ°ú ÇÔ²², ¹ÙÀÌ¿ÀÀǾàǰ »ý»êÀÌ Áõ°¡Çϰí ÀÖ´Â °Í ¶ÇÇÑ ¿¹Ãø ±â°£¿¡ ¼¼°èÀÇ DNases ½ÃÀå ¼ºÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå °³¿ä

Á¦3Àå DNases ½ÃÀå : ÀÀ¿ë ºñÁî´Ï½º ºÐ¼®

Á¦4Àå DNases ½ÃÀå : °æÀï ±¸µµ ȯ°æ

Á¦5Àå ¸®°¡¾ÆÁ¦ ½ÃÀå : ÀÀ¿ë ºñÁî´Ï½º ºÐ¼®

Á¦6Àå ¸®°¡¾ÆÁ¦ ½ÃÀå °æÀï ±¸µµ ȯ°æ

Á¦7Àå RNA ÁßÇÕÈ¿¼Ò ½ÃÀå : ÀÀ¿ë ºñÁî´Ï½º ºÐ¼®

Á¦8Àå RNA ÁßÇÕÈ¿¼Ò ½ÃÀå : °æÀï ±¸µµ

Á¦9Àå DNases, ¸®°¡¾ÆÁ¦, RNA ÁßÇÕÈ¿¼Ò ½ÃÀå : Áö¿ª ºñÁî´Ï½º ºÐ¼®

LSH 22.11.17
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

DNases, Ligases, And RNA Polymerases Market Growth & Trends:

The global DNases, ligases, and RNA polymerases market size is expected to reach USD 1.28 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 8.58% from 2022 to 2030. Increasing research and development expenditure is one of the key factors fueling market growth. Furthermore, rising biopharmaceutical production along with a focus on DNA-related innovations is expected to positively impact the global DNases market growth over the forecast period.

For instance, in June 2020, Alphazyme and Codexis entered into a strategic partnership to provide novel enzymes for diagnostics and research. DNases have continued to garner a significant market share in recent years owing to factors such as an increase in the adoption of DNA enzymes related to pharmaceuticals, which are essential for the treatment of various chronic disorders and digestive diseases. In addition, developments in the biotechnology and pharmaceutical fields, such as the introduction of genetic and protein engineering, have helped in expanding applications of enzymes, which is expected to offer lucrative growth opportunities in the forecast period.

An increase in R&D investments to develop ligases as the target for therapeutic applications in cancer is estimated to drive the segment in the forecast period. In addition, strategic activities by major manufacturers will offer lucrative growth opportunities in the projected period. Other factors augmenting segment growth include advancements in healthcare, increasing demand for modernization in the field of medical academics and life sciences, growing investments by governments to develop genomic technologies, and a surge in the demand for oligonucleotide synthesis by private and public research firms.

The COVID-19 pandemic situation has offered lucrative opportunities for RNA polymerase applications. Currently, there are over 150 vaccines and therapeutics that either use mRNA in their production processes or are based on mRNA molecules, which are being assessed for the treatment of a wide range of indications. Many mRNA vaccines are approved for emergency use in many countries across the globe.

For instance, Moderna's mRNA-1273 and BioNTech/ Pfizer BNT-162 vaccines have been approved for use across various regions globally. Moreover, there are instances of huge capital investments for the development of mRNA vaccines. For instance, in June 2021, Sanofi declared an investment of around USD 452.12 annually for its mRNA vaccines development center.

DNases, Ligases, And RNA Polymerases Market Report Highlights:

Table of Contents

Chapter 1 Methodology and Scope

Chapter 2 Executive Summary

Chapter 3 DNases Market: Application Business Analysis

Chapter 4 DNases Market: Competitive Landscape

Chapter 5 Ligases Market: Application Business Analysis

Chapter 6 Ligases Market Competitive Landscape

Chapter 7 RNA Polymerases Market: Application Business Analysis

Chapter 8 RNA Polymerases Market: Competitive Landscape

Chapter 9 DNases, Ligases, RNA Polymerases Market: Regional Business Analysis

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â